April 23, 2018 / 3:38 PM / a month ago

BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave

April 23 (Reuters) - Pernix Therapeutics Holdings Inc :

* PERNIX THERAPEUTICS ANNOUNCES PARTICIPATION IN LEAD BID FOR ACQUISITION OF WORLDWIDE RIGHTS TO CONTRAVE® FOR WEIGHT LOSS

* PERNIX THERAPEUTICS HOLDINGS - TO PARTICIPATE IN INVESTOR GROUP THAT ENTERED INTO “STALKING HORSE” ASSET PURCHASE DEAL TO ACQUIRE SOME ASSETS OF OREXIGEN THERAPEUTICS

* PERNIX THERAPEUTICS HOLDINGS - WOULD CONTRIBUTE 10% OF CAPITAL REQUIRED TO FUND PURCHASE PRICE OF DEAL, OR $7.5 MILLION

* PERNIX THERAPEUTICS - WOULD CONTRIBUTE 10% OF CAPITAL REQUIRED TO FUND PURCHASE PRICE, OR $7.5 MILLION, FUNDED THROUGH DRAW UNDER EXISTING DELAYED DRAW TERM LOAN FACILITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below